About Sequent Scientific Limited
Data last updated: 23 December 2025
Sequent Scientific Limited is a public limited company based in Shaikpet, Telangana, India. It specialises in pharmaceuticals, a part of the broader chemicals sector. Incorporated on 28 June 1985, the company has been in operation for over 41 years.
Registered with ROC Hyderabad under CIN L99999MH1985PLC036685. Listed on BSE: 512529 and NSE: EQUENT.
Capital: an authorised share capital of ₹886.15 Cr and a paid-up capital of ₹50.82 Cr. Formerly known as Visistha Trades & Finance Limited and P.I. Drugs & Pharmaceuticals Limited. It is led by directors including Gregory John Andrews and Fabian Martin Kausche.
Last AGM: 08 August 2025. Financial statements filed for year ended 31 March 2025. Office: Shaikpet, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,566.06 Cr, a growth of 13% compared to the previous year.
The company has a workforce of approximately 399 employees as per the latest available data.
As per MCA filings, the company has open charges of ₹792.71 Cr and satisfied charges of ₹1,663.84 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sequent.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered Address3Rd Floor Srivalli S Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet, Shaikpet, Telangana, India – 500033
-
IndustryChemicals, Pharmaceuticals, Medicinal Chemical & Botanical Products, Chemical Products
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Sequent Scientific Limited
Sequent Scientific Limited has undergone 3 name changes throughout its history. The company was previously known as Visistha Trades & Finance Limited, P.I. Drugs & Pharmaceuticals Limited, and Visistha Trades And Finance Limited. The current legal name is Sequent Scientific Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Sequent Scientific Limited | Current |
| Visistha Trades & Finance Limited | Previous |
| P.I. Drugs & Pharmaceuticals Limited | Previous |
| Visistha Trades And Finance Limited | Previous |
CIN History of Sequent Scientific Limited
Sequent Scientific Limited has one previous CIN (Corporate Identification Number): L99999MH1985PLC036685. The current CIN is L99999TS1985PLC196357, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L99999TS1985PLC196357 | Current |
| L99999MH1985PLC036685 | Previous |
Business Activity of Sequent Scientific Limited
Sequent Scientific Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Sequent Scientific Limited
Sequent Scientific Limited is audited by SRBC & CO LLP (ICAI peer reviewed, certificate valid till 2029-02-28) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| SRBC & CO LLP (ICAI peer reviewed, certificate valid till 2029-02-28) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Sequent Scientific Limited
Sequent Scientific Limited is currently managed by 8 directors, with 42 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gregory John Andrews | Director | 06 Nov 2020 | 5 Years 8 Months | Current |
| Fabian Martin Kausche | Director | 14 Dec 2020 | 5 Years 6 Months | Current |
| Revati Parag Kasture | Director | 17 Dec 2024 | 1 Years 6 Months | Current |
|
Milind Shripad Sarwate
Also directs:
Increate Value Advisors Llp, Increate Social Value Advisors & Resourcers Llp, Asian Paints Limited and 5 more
|
Director | 25 Aug 2020 | 5 Years 10 Months | Current |
|
Kamal Kishore Sharma
Also directs:
Templecraft Realty Llp, Templeriviere Property Llp, Temple Wellness Ventures Llp and 4 more
|
Director | 25 Aug 2020 | 5 Years 10 Months | Current |
|
Anuj Vishnukumar Poddar
Also directs:
Highway Roop Precision Technologies Limited, Vlcc Limited
|
Director | 05 Sep 2025 | 0 Years 10 Months | Current |
Financials of Sequent Scientific Limited FY 2026 filings available
Sequent Scientific Limited reported revenue of ₹3,420.31 Cr (up 120.47% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹3,420.31 Cr | ₹1,551.37 Cr | ₹1,369.73 Cr | ₹1,420.91 Cr | ₹1,412.82 Cr | ₹1,361.62 Cr | ₹1,179.24 Cr |
| Other Income | ₹43.55 Cr | ₹14.69 Cr | ₹10.96 Cr | ₹6.39 Cr | ₹10.85 Cr | ₹8.36 Cr | ₹10.09 Cr |
| Total Income | ₹3,463.86 Cr | ₹1,566.06 Cr | ₹1,380.69 Cr | ₹1,427.3 Cr | ₹1,423.66 Cr | ₹1,369.98 Cr | ₹1,189.33 Cr |
| Cost of Materials Consumed | ₹1,376.93 Cr | ₹617.37 Cr | ₹613.67 Cr | ₹693.1 Cr | ₹670.52 Cr | ₹588.67 Cr | ₹508.69 Cr |
| Purchases of Stock-in-Trade | ₹250.59 Cr | ₹212.57 Cr | ₹175.54 Cr | ₹121.77 Cr | ₹171.89 Cr | ₹145.02 Cr | ₹88.89 Cr |
| Changes in Inventories | -₹64.79 Cr | -₹18.09 Cr | -₹29.46 Cr | ₹18.9 Cr | -₹49.42 Cr | -₹39.03 Cr | ₹7.47 Cr |
| Employee Benefit Expense | ₹565.5 Cr | ₹281.12 Cr | ₹250.57 Cr | ₹258.39 Cr | ₹231.37 Cr | ₹187.22 Cr | ₹165.06 Cr |
| Finance Costs | ₹69.21 Cr | ₹60.75 Cr | ₹48.09 Cr | ₹35.52 Cr | ₹15.77 Cr | ₹24.38 Cr | ₹35.71 Cr |
| Depreciation & Amortisation | ₹233.64 Cr | ₹66.45 Cr | ₹61.54 Cr | ₹55.69 Cr | ₹51.09 Cr | ₹50.6 Cr | ₹50.62 Cr |
| Other Expenses | ₹639.55 Cr | ₹296.61 Cr | ₹298 Cr | ₹316.8 Cr | ₹279.05 Cr | ₹267.67 Cr | ₹238.81 Cr |
| Total Expenses | ₹3,070.63 Cr | ₹1,516.78 Cr | ₹1,417.94 Cr | ₹1,500.16 Cr | ₹1,370.28 Cr | ₹1,224.53 Cr | ₹1,095.26 Cr |
| Profit Before Exceptional Items & Tax | ₹393.23 Cr | ₹49.28 Cr | -₹37.26 Cr | -₹72.87 Cr | ₹53.39 Cr | ₹145.45 Cr | ₹94.08 Cr |
| Exceptional Items | -₹44.21 Cr | -₹4.97 Cr | -₹17.39 Cr | -₹64.79 Cr | ₹0 | -₹8.82 Cr | ₹0 |
| Profit Before Tax | ₹349.02 Cr | ₹44.31 Cr | -₹54.65 Cr | -₹137.66 Cr | ₹53.39 Cr | ₹136.63 Cr | ₹94.08 Cr |
| Total Tax Expense | ₹124.37 Cr | ₹12.05 Cr | -₹25.03 Cr | -₹15.68 Cr | ₹8.33 Cr | ₹32.18 Cr | ₹12.03 Cr |
| Net Profit | ₹224.65 Cr | ₹32.26 Cr | -₹29.61 Cr | -₹121.98 Cr | ₹45.06 Cr | ₹104.45 Cr | ₹82.05 Cr |
| attributable to Owners | ₹177.28 Cr | ₹21.88 Cr | -₹35.87 Cr | -₹121.16 Cr | ₹41.25 Cr | ₹95.44 Cr | ₹69.91 Cr |
| attributable to NCI | ₹47.37 Cr | ₹10.38 Cr | ₹6.26 Cr | -₹81.8 Lakh | ₹3.81 Cr | ₹9.01 Cr | ₹12.14 Cr |
| Other Comprehensive Income | ₹106.9 Cr | -₹21.61 Cr | -₹65.15 Cr | -₹26.15 Cr | -₹108.66 Cr | ₹64.42 Cr | -₹31.79 Cr |
| Total Comprehensive Income | ₹331.55 Cr | ₹10.65 Cr | -₹94.77 Cr | -₹148.13 Cr | -₹63.6 Cr | ₹168.88 Cr | ₹50.26 Cr |
| EBITDA (computed) | ₹696.08 Cr | ₹176.48 Cr | ₹72.37 Cr | ₹18.35 Cr | ₹120.25 Cr | ₹220.43 Cr | ₹180.41 Cr |
| Basic EPS | ₹4.09 | ₹0.88 | ₹-1.44 | ₹-4.88 | ₹1.67 | ₹3.87 | ₹2.87 |
| Diluted EPS | ₹4.01 | ₹0.85 | ₹-1.44 | ₹-4.88 | ₹1.65 | ₹3.85 | ₹2.85 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹4,628.39 Cr | ₹1,601.95 Cr | ₹1,540.38 Cr | ₹1,529.12 Cr |
| Non-current Assets | ₹2,373.84 Cr | ₹728.22 Cr | ₹717.53 Cr | ₹739.24 Cr |
| Current Assets | ₹2,254.55 Cr | ₹872.92 Cr | ₹810.94 Cr | ₹779.79 Cr |
| Property, Plant & Equipment | ₹1,137.9 Cr | ₹231.62 Cr | ₹248.62 Cr | ₹300.74 Cr |
| Inventories | ₹803.2 Cr | ₹385.32 Cr | ₹346.23 Cr | ₹346.09 Cr |
| Trade Receivables | ₹1,045.23 Cr | ₹363.17 Cr | ₹335.63 Cr | ₹340.96 Cr |
| Cash & Equivalents | ₹255.76 Cr | ₹62.66 Cr | ₹64.81 Cr | ₹41.57 Cr |
| Equity (Net Worth) | ₹3,114.73 Cr | ₹770.36 Cr | ₹712.96 Cr | ₹749.19 Cr |
| Equity Share Capital | ₹87.37 Cr | ₹50.06 Cr | ₹49.89 Cr | ₹49.89 Cr |
| Borrowings (Non-current) | ₹302.1 Cr | ₹273.88 Cr | ₹142.72 Cr | ₹182.8 Cr |
| Borrowings (Current) | ₹133.72 Cr | ₹172.5 Cr | ₹308.56 Cr | ₹215.1 Cr |
| Total Debt (computed) | ₹435.82 Cr | ₹446.38 Cr | ₹451.28 Cr | ₹397.9 Cr |
| Current Liabilities | ₹945.9 Cr | ₹505.01 Cr | ₹626.99 Cr | ₹526.07 Cr |
| Total Liabilities | ₹1,513.66 Cr | ₹831.59 Cr | ₹827.43 Cr | ₹779.93 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹322.91 Cr | ₹83.36 Cr | ₹30.59 Cr | ₹16.81 Cr | ₹30.6 Cr |
| Investing Cash Flow | -₹84.12 Cr | -₹24.78 Cr | -₹5.92 Cr | -₹64.96 Cr | -₹94.1 Cr |
| Financing Cash Flow | -₹123.33 Cr | -₹60.73 Cr | -₹1.44 Cr | ₹32.23 Cr | ₹67.26 Cr |
| Capital Expenditure | ₹134.72 Cr | ₹39.09 Cr | ₹30.81 Cr | ₹86.18 Cr | ₹32.46 Cr |
| Free Cash Flow (computed) | ₹188.19 Cr | ₹44.27 Cr | -₹21.22 Lakh | -₹69.37 Cr | -₹1.87 Cr |
| Dividends Paid | ₹4.91 Cr | ₹1.85 Cr | ₹0 | ₹0 | ₹12.34 Cr |
| Net Change in Cash | ₹115.46 Cr | -₹2.15 Cr | ₹23.24 Cr | -₹15.92 Cr | ₹3.75 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹919.96 Cr | ₹858.41 Cr | ₹423.99 Cr | ₹441.42 Cr | ₹401.7 Cr | ₹390.81 Cr | ₹368.65 Cr | ₹390.21 Cr | ₹361.2 Cr | ₹329.36 Cr | ₹345.97 Cr | ₹333.21 Cr |
| Other Income | ₹15.92 Cr | ₹13.98 Cr | ₹2.15 Cr | ₹3.87 Cr | ₹1.66 Cr | ₹5.84 Cr | ₹4.51 Cr | ₹2.68 Cr | ₹4 Cr | ₹4.52 Cr | ₹1.65 Cr | ₹79.3 Lakh |
| Total Income | ₹935.88 Cr | ₹872.39 Cr | ₹426.14 Cr | ₹445.29 Cr | ₹403.36 Cr | ₹396.65 Cr | ₹373.16 Cr | ₹392.89 Cr | ₹365.2 Cr | ₹333.88 Cr | ₹347.62 Cr | ₹334 Cr |
| Cost of Materials Consumed | ₹363.92 Cr | ₹347.29 Cr | ₹182.79 Cr | ₹179.69 Cr | ₹159 Cr | ₹169.93 Cr | ₹135.34 Cr | ₹153.1 Cr | ₹166.37 Cr | ₹145.69 Cr | ₹156.62 Cr | ₹144.99 Cr |
| Purchases of Stock-in-Trade | ₹92.01 Cr | ₹56.58 Cr | ₹45.14 Cr | ₹52.1 Cr | ₹36.6 Cr | ₹41.79 Cr | ₹65.96 Cr | ₹68.22 Cr | ₹41.37 Cr | ₹38.22 Cr | ₹49.68 Cr | ₹46.27 Cr |
| Changes in Inventories | -₹43.1 Cr | -₹12.94 Cr | -₹14.83 Cr | ₹2.76 Cr | ₹4.14 Cr | -₹9.19 Cr | -₹6.01 Cr | -₹7.03 Cr | -₹13.2 Cr | -₹3.28 Cr | -₹16.53 Cr | ₹3.55 Cr |
| Employee Benefit Expense | ₹149.82 Cr | ₹137.69 Cr | ₹81.69 Cr | ₹79.07 Cr | ₹76.81 Cr | ₹75.22 Cr | ₹67.04 Cr | ₹62.05 Cr | ₹62.19 Cr | ₹57.86 Cr | ₹66.36 Cr | ₹64.17 Cr |
| Finance Costs | ₹14.52 Cr | ₹16.75 Cr | ₹13.51 Cr | ₹14.16 Cr | ₹15.13 Cr | ₹14.95 Cr | ₹14.29 Cr | ₹16.38 Cr | ₹12.44 Cr | ₹12.58 Cr | ₹12.58 Cr | ₹10.48 Cr |
| Depreciation & Amortisation | ₹60.41 Cr | ₹58.53 Cr | ₹15.46 Cr | ₹15.13 Cr | ₹16.12 Cr | ₹16.98 Cr | ₹17.1 Cr | ₹16.25 Cr | ₹16.48 Cr | ₹15.46 Cr | ₹15.36 Cr | ₹14.24 Cr |
| Other Expenses | ₹173.06 Cr | ₹154.16 Cr | ₹73.52 Cr | ₹75.61 Cr | ₹78.91 Cr | ₹78.56 Cr | ₹67.22 Cr | ₹71.92 Cr | ₹72.2 Cr | ₹68.62 Cr | ₹74.71 Cr | ₹82.47 Cr |
| Total Expenses | ₹810.64 Cr | ₹758.06 Cr | ₹397.28 Cr | ₹418.52 Cr | ₹386.71 Cr | ₹388.24 Cr | ₹360.94 Cr | ₹380.89 Cr | ₹357.85 Cr | ₹335.15 Cr | ₹358.78 Cr | ₹366.17 Cr |
| Profit Before Exceptional Items & Tax | ₹125.24 Cr | ₹114.33 Cr | ₹28.86 Cr | ₹26.77 Cr | ₹16.65 Cr | ₹8.41 Cr | ₹12.22 Cr | ₹12 Cr | ₹7.34 Cr | -₹1.27 Cr | -₹11.16 Cr | -₹32.17 Cr |
| Exceptional Items | ₹0 | -₹41.26 Cr | -₹1.7 Cr | -₹1.25 Cr | -₹34 Lakh | -₹31 Lakh | -₹4.32 Cr | ₹0 | -₹4.71 Cr | ₹2.76 Cr | ₹8.07 Cr | -₹23.51 Cr |
| Profit Before Tax | ₹125.24 Cr | ₹73.07 Cr | ₹27.16 Cr | ₹25.52 Cr | ₹16.31 Cr | ₹8.1 Cr | ₹7.9 Cr | ₹12 Cr | ₹2.64 Cr | ₹1.49 Cr | -₹3.09 Cr | -₹55.68 Cr |
| Total Tax Expense | ₹58.86 Cr | ₹24.55 Cr | ₹7.56 Cr | ₹7.95 Cr | ₹5.93 Cr | ₹1.62 Cr | ₹1.56 Cr | ₹2.94 Cr | ₹1.36 Cr | -₹9.19 Cr | ₹3.79 Cr | -₹21 Cr |
| Net Profit | ₹66.38 Cr | ₹48.52 Cr | ₹19.6 Cr | ₹17.57 Cr | ₹10.38 Cr | ₹6.48 Cr | ₹6.34 Cr | ₹9.06 Cr | ₹1.27 Cr | ₹10.68 Cr | -₹6.88 Cr | -₹34.68 Cr |
| attributable to Owners | ₹52.11 Cr | ₹38.44 Cr | ₹14.74 Cr | ₹14.31 Cr | ₹9.32 Cr | ₹3.44 Cr | - | ₹6.51 Cr | -₹91.1 Lakh | ₹8.27 Cr | -₹8.38 Cr | -₹34.85 Cr |
| attributable to NCI | ₹14.27 Cr | ₹10.08 Cr | ₹4.86 Cr | ₹3.26 Cr | ₹1.06 Cr | ₹3.04 Cr | - | ₹2.55 Cr | ₹2.19 Cr | ₹2.41 Cr | ₹1.5 Cr | ₹16.5 Lakh |
| Other Comprehensive Income | ₹39.02 Cr | ₹2.91 Cr | ₹14.35 Cr | ₹31.75 Cr | ₹46.75 Cr | -₹56.86 Cr | ₹19.29 Cr | -₹30.79 Cr | -₹21.69 Cr | ₹4.82 Cr | -₹15.29 Cr | -₹32.98 Cr |
| Total Comprehensive Income | ₹105.4 Cr | ₹51.43 Cr | ₹33.95 Cr | ₹49.32 Cr | ₹57.13 Cr | -₹50.38 Cr | ₹25.63 Cr | -₹21.73 Cr | -₹20.42 Cr | ₹15.49 Cr | -₹22.18 Cr | -₹67.66 Cr |
| EBITDA (computed) | ₹200.17 Cr | ₹189.61 Cr | ₹57.83 Cr | ₹56.06 Cr | ₹47.9 Cr | ₹40.34 Cr | ₹43.61 Cr | ₹44.63 Cr | ₹36.27 Cr | ₹26.77 Cr | ₹16.78 Cr | -₹7.44 Cr |
| Basic EPS | ₹1.20 | ₹0.89 | ₹0.59 | ₹0.57 | ₹0.37 | ₹0.14 | ₹0.10 | ₹0.26 | ₹-0.04 | ₹0.33 | ₹-0.34 | ₹-1.40 |
| Diluted EPS | ₹1.17 | ₹0.87 | ₹0.58 | ₹0.56 | ₹0.36 | ₹0.13 | ₹0.10 | ₹0.26 | ₹-0.04 | ₹0.33 | ₹-0.34 | ₹-1.40 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,382.06 Cr | ₹178.26 Cr | ₹168.52 Cr | ₹222.69 Cr | ₹219.63 Cr | ₹265.46 Cr | ₹227.33 Cr |
| Other Income | ₹66.26 Cr | ₹50.94 Cr | ₹45.98 Cr | ₹28.24 Cr | ₹27.64 Cr | ₹19.97 Cr | ₹14.56 Cr |
| Total Income | ₹1,448.32 Cr | ₹229.2 Cr | ₹214.5 Cr | ₹250.93 Cr | ₹247.27 Cr | ₹285.42 Cr | ₹241.89 Cr |
| Cost of Materials Consumed | ₹599.82 Cr | ₹86.91 Cr | ₹102.54 Cr | ₹114.07 Cr | ₹124.01 Cr | ₹115.88 Cr | ₹108.69 Cr |
| Purchases of Stock-in-Trade | ₹28.41 Cr | ₹10.28 Cr | ₹0 | ₹2.42 Cr | ₹4.38 Cr | ₹8.55 Cr | ₹8.24 Cr |
| Changes in Inventories | -₹4.36 Cr | ₹8.31 Cr | ₹5.35 Cr | ₹19.42 Cr | -₹19.73 Cr | -₹15.56 Cr | -₹3.89 Cr |
| Employee Benefit Expense | ₹213.75 Cr | ₹35.05 Cr | ₹30.05 Cr | ₹36.66 Cr | ₹27.38 Cr | ₹22.42 Cr | ₹17.1 Cr |
| Finance Costs | ₹16.21 Cr | ₹3.96 Cr | ₹4.36 Cr | ₹2.51 Cr | ₹1.61 Cr | ₹2.68 Cr | ₹5.04 Cr |
| Depreciation & Amortisation | ₹124.15 Cr | ₹8.67 Cr | ₹8.94 Cr | ₹9.12 Cr | ₹9.59 Cr | ₹9.13 Cr | ₹8.95 Cr |
| Other Expenses | ₹309.91 Cr | ₹49.09 Cr | ₹57.24 Cr | ₹76.47 Cr | ₹84.34 Cr | ₹98.88 Cr | ₹74.96 Cr |
| Total Expenses | ₹1,287.89 Cr | ₹202.27 Cr | ₹208.48 Cr | ₹260.67 Cr | ₹231.58 Cr | ₹241.97 Cr | ₹219.08 Cr |
| Profit Before Exceptional Items & Tax | ₹160.43 Cr | ₹26.93 Cr | ₹6.02 Cr | -₹9.75 Cr | ₹15.69 Cr | ₹43.45 Cr | ₹22.81 Cr |
| Exceptional Items | -₹44.21 Cr | -₹4.88 Cr | -₹6.25 Cr | ₹0 | ₹0 | -₹2.56 Cr | ₹0 |
| Profit Before Tax | ₹116.22 Cr | ₹22.05 Cr | -₹23.9 Lakh | -₹9.75 Cr | ₹15.69 Cr | ₹40.89 Cr | ₹22.81 Cr |
| Total Tax Expense | ₹40.35 Cr | ₹6.25 Cr | -₹86.1 Lakh | -₹3.67 Cr | ₹89.1 Lakh | ₹8.77 Cr | ₹1.47 Cr |
| Net Profit | ₹75.87 Cr | ₹15.8 Cr | ₹62.2 Lakh | -₹6.08 Cr | ₹14.8 Cr | ₹32.11 Cr | ₹21.34 Cr |
| Other Comprehensive Income | -₹98 Lakh | -₹15 Lakh | ₹3.2 Lakh | -₹12.05 Cr | -₹35.32 Cr | ₹90.48 Cr | -₹48.58 Cr |
| Total Comprehensive Income | ₹74.89 Cr | ₹15.65 Cr | ₹65.4 Lakh | -₹18.13 Cr | -₹20.52 Cr | ₹122.59 Cr | -₹27.24 Cr |
| EBITDA (computed) | ₹300.79 Cr | ₹39.56 Cr | ₹19.32 Cr | ₹1.88 Cr | ₹26.89 Cr | ₹55.26 Cr | ₹36.8 Cr |
| Basic EPS | ₹1.75 | ₹0.63 | ₹0.03 | ₹-0.24 | ₹0.60 | ₹1.30 | ₹0.88 |
| Diluted EPS | ₹1.72 | ₹0.62 | ₹0.03 | ₹-0.24 | ₹0.59 | ₹1.30 | ₹0.87 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹3,655.04 Cr | ₹1,222.2 Cr | ₹1,187.6 Cr | ₹1,122.77 Cr |
| Non-current Assets | ₹2,692.59 Cr | ₹1,114.68 Cr | ₹1,082.42 Cr | ₹1,037.66 Cr |
| Current Assets | ₹962.45 Cr | ₹107.52 Cr | ₹96.77 Cr | ₹75.02 Cr |
| Property, Plant & Equipment | ₹802.72 Cr | ₹45.47 Cr | ₹41.66 Cr | ₹56.5 Cr |
| Inventories | ₹292.87 Cr | ₹25.05 Cr | ₹34.54 Cr | ₹47.95 Cr |
| Trade Receivables | ₹554.26 Cr | ₹68.93 Cr | ₹44.79 Cr | ₹13.65 Cr |
| Cash & Equivalents | ₹20.97 Cr | ₹3 Lakh | ₹92.6 Lakh | ₹8.3 Lakh |
| Equity (Net Worth) | ₹3,189.07 Cr | ₹1,142.65 Cr | ₹1,087.23 Cr | ₹1,058.36 Cr |
| Equity Share Capital | ₹87.37 Cr | ₹50.06 Cr | ₹49.89 Cr | ₹49.89 Cr |
| Borrowings (Non-current) | ₹6.32 Cr | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹25.8 Cr | ₹44.38 Cr | ₹46.46 Cr | ₹19.1 Cr |
| Total Debt (computed) | ₹32.12 Cr | ₹44.38 Cr | ₹46.46 Cr | ₹19.1 Cr |
| Current Liabilities | ₹415.77 Cr | ₹75.56 Cr | ₹98.16 Cr | ₹61.61 Cr |
| Total Liabilities | ₹465.97 Cr | ₹79.55 Cr | ₹100.37 Cr | ₹64.41 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹119.12 Cr | -₹1.12 Cr | -₹26.94 Cr | ₹37.75 Cr | ₹9.36 Cr |
| Investing Cash Flow | -₹106.88 Cr | -₹44 Lakh | ₹5.47 Cr | -₹50.7 Cr | -₹4.25 Cr |
| Financing Cash Flow | -₹7.06 Cr | ₹66 Lakh | ₹22.32 Cr | ₹24.1 Lakh | ₹7.25 Cr |
| Capital Expenditure | ₹100.93 Cr | ₹11.91 Cr | ₹9.54 Cr | ₹8.86 Cr | ₹6.45 Cr |
| Free Cash Flow (computed) | ₹18.19 Cr | -₹13.03 Cr | -₹36.48 Cr | ₹28.88 Cr | ₹2.92 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹12.34 Cr |
| Net Change in Cash | ₹5.18 Cr | -₹90 Lakh | ₹84.3 Lakh | -₹12.71 Cr | ₹12.36 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹372.49 Cr | ₹341.64 Cr | ₹34.03 Cr | ₹41.07 Cr | ₹42.33 Cr | ₹36.27 Cr | ₹41.99 Cr | ₹57.67 Cr | ₹36.77 Cr | ₹42.21 Cr | ₹49.12 Cr | ₹40.42 Cr |
| Other Income | ₹19.75 Cr | ₹16.29 Cr | ₹11.75 Cr | ₹11.48 Cr | ₹12.27 Cr | ₹11.88 Cr | ₹15.95 Cr | ₹10.84 Cr | ₹12.98 Cr | ₹13.44 Cr | ₹9.87 Cr | ₹9.7 Cr |
| Total Income | ₹392.24 Cr | ₹357.93 Cr | ₹45.78 Cr | ₹52.55 Cr | ₹54.6 Cr | ₹48.15 Cr | ₹57.94 Cr | ₹68.51 Cr | ₹49.75 Cr | ₹55.65 Cr | ₹58.99 Cr | ₹50.12 Cr |
| Cost of Materials Consumed | ₹156.16 Cr | ₹155.03 Cr | ₹16.8 Cr | ₹19.76 Cr | ₹21.42 Cr | ₹22.55 Cr | ₹24.52 Cr | ₹18.42 Cr | ₹23.68 Cr | ₹27.17 Cr | ₹23.35 Cr | ₹28.35 Cr |
| Purchases of Stock-in-Trade | ₹18.21 Cr | ₹5.44 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹10.28 Cr | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | -₹4.04 Cr | -₹9.66 Cr | -₹1.26 Cr | ₹1.72 Cr | ₹87 Lakh | -₹3.25 Cr | -₹48 Lakh | ₹11.17 Cr | -₹65.7 Lakh | -₹2.83 Cr | ₹11.83 Cr | -₹3 Cr |
| Employee Benefit Expense | ₹57.45 Cr | ₹50.1 Cr | ₹9.46 Cr | ₹9.48 Cr | ₹10.58 Cr | ₹9.3 Cr | ₹8.04 Cr | ₹7.13 Cr | ₹7.09 Cr | ₹7.12 Cr | ₹7.22 Cr | ₹8.62 Cr |
| Finance Costs | ₹2.53 Cr | ₹3.56 Cr | ₹83 Lakh | ₹1.08 Cr | ₹99 Lakh | ₹1.17 Cr | ₹1 Cr | ₹81 Lakh | ₹1.03 Cr | ₹1.15 Cr | ₹1.21 Cr | ₹98.2 Lakh |
| Depreciation & Amortisation | ₹31.16 Cr | ₹31.2 Cr | ₹2.24 Cr | ₹2.33 Cr | ₹2.3 Cr | ₹2.24 Cr | ₹2.12 Cr | ₹2 Cr | ₹2.11 Cr | ₹2.05 Cr | ₹2.35 Cr | ₹2.43 Cr |
| Other Expenses | ₹82.02 Cr | ₹70.39 Cr | ₹11.67 Cr | ₹12.15 Cr | ₹12.28 Cr | ₹12.15 Cr | ₹12.01 Cr | ₹12.65 Cr | ₹12.4 Cr | ₹14.9 Cr | ₹14.42 Cr | ₹15.53 Cr |
| Total Expenses | ₹343.49 Cr | ₹306.06 Cr | ₹39.74 Cr | ₹46.52 Cr | ₹48.44 Cr | ₹44.16 Cr | ₹47.21 Cr | ₹62.46 Cr | ₹45.65 Cr | ₹49.56 Cr | ₹60.38 Cr | ₹52.9 Cr |
| Profit Before Exceptional Items & Tax | ₹48.75 Cr | ₹51.87 Cr | ₹6.04 Cr | ₹6.03 Cr | ₹6.16 Cr | ₹3.99 Cr | ₹10.73 Cr | ₹6.05 Cr | ₹4.1 Cr | ₹6.09 Cr | -₹1.4 Cr | -₹2.78 Cr |
| Exceptional Items | ₹0 | -₹41.26 Cr | -₹1.7 Cr | -₹1.25 Cr | -₹25 Lakh | -₹31 Lakh | -₹4.32 Cr | ₹0 | ₹0 | ₹0 | ₹0 | -₹6.25 Cr |
| Profit Before Tax | ₹48.75 Cr | ₹10.61 Cr | ₹4.34 Cr | ₹4.78 Cr | ₹5.91 Cr | ₹3.68 Cr | ₹6.41 Cr | ₹6.05 Cr | ₹4.1 Cr | ₹6.09 Cr | -₹1.4 Cr | -₹9.03 Cr |
| Total Tax Expense | ₹12.94 Cr | ₹10.69 Cr | ₹1.26 Cr | ₹1.41 Cr | ₹1.68 Cr | ₹87 Lakh | ₹2.15 Cr | ₹1.55 Cr | ₹33.7 Lakh | ₹1.51 Cr | -₹47.8 Lakh | -₹2.23 Cr |
| Net Profit | ₹35.81 Cr | -₹8 Lakh | ₹3.08 Cr | ₹3.37 Cr | ₹4.23 Cr | ₹2.81 Cr | ₹4.26 Cr | ₹4.5 Cr | ₹3.76 Cr | ₹4.58 Cr | -₹91.8 Lakh | -₹6.8 Cr |
| Other Comprehensive Income | -₹80 Lakh | -₹25 Lakh | ₹7 Lakh | ₹0 | -₹11 Lakh | -₹1 Lakh | -₹2 Lakh | -₹1 Lakh | -₹50,000 | ₹30,000 | ₹2.7 Lakh | ₹0 |
| Total Comprehensive Income | ₹35.01 Cr | -₹33 Lakh | ₹3.15 Cr | ₹3.37 Cr | ₹4.12 Cr | ₹2.8 Cr | ₹4.24 Cr | ₹4.49 Cr | ₹3.76 Cr | ₹4.58 Cr | -₹89.1 Lakh | -₹6.8 Cr |
| EBITDA (computed) | ₹82.44 Cr | ₹86.63 Cr | ₹9.11 Cr | ₹9.44 Cr | ₹9.45 Cr | ₹7.4 Cr | ₹13.85 Cr | ₹8.86 Cr | ₹7.23 Cr | ₹9.29 Cr | ₹2.17 Cr | ₹62.8 Lakh |
| Basic EPS | ₹0.82 | ₹0.00 | ₹0.12 | ₹0.14 | ₹0.17 | ₹0.11 | ₹0.17 | ₹0.18 | ₹0.15 | ₹0.18 | ₹-0.04 | ₹-0.27 |
| Diluted EPS | ₹0.81 | ₹0.00 | ₹0.12 | ₹0.13 | ₹0.16 | ₹0.11 | ₹0.17 | ₹0.18 | ₹0.15 | ₹0.18 | ₹-0.04 | ₹-0.27 |
Board & Governance of Sequent Scientific Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Sequent Scientific Limited has 9 directors - 3 independent and 3 executive. The board is chaired by Kamal Kishore Sharma.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Hari Babu Bodepudi | Executive Director · CEO-MD | 2023-08-07 | 1 |
| Kamal Kishore Sharma | Non-Executive - Independent Director · Chairperson | 2020-08-25 | 1 |
| Milind Shripad Sarwate | Non-Executive - Independent Director | 2020-08-25 | 6 |
| Revati Parag Kasture | Non-Executive - Independent Director | 2024-12-17 | 1 |
| Rajaram Narayanan | Executive Director | 2022-04-11 | 1 |
| Srinivas Vasireddy | Executive Director | 2025-12-16 | 1 |
| Gregory John Andrews | Non-Executive - Non Independent Director | 2020-11-06 | 1 |
| Fabian Martin Kausche | Non-Executive - Non Independent Director | 2020-12-14 | 1 |
| Anuj Vishnukumar Poddar | Non-Executive - Non Independent Director | 2025-09-05 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Milind Shripad Sarwate (Chairperson), Kamal Kishore Sharma, Revati Parag Kasture, Anuj Vishnukumar Poddar |
| Nomination and remuneration committee | Milind Shripad Sarwate (Chairperson), Kamal Kishore Sharma, Anuj Vishnukumar Poddar |
| Stakeholders Relationship Committee | Revati Parag Kasture (Chairperson), Milind Shripad Sarwate, Rajaram Narayanan, Hari Babu Bodepudi |
| Risk Management Committee | Anuj Vishnukumar Poddar (Chairperson), Milind Shripad Sarwate, Rajaram Narayanan, Hari Babu Bodepudi, Revati Parag Kasture, Ramakant Singani |
| Corporate Social Responsibility Committee | Kamal Kishore Sharma (Chairperson), Rajaram Narayanan, Hari Babu Bodepudi |
Charges & Borrowings of Sequent Scientific Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Oct 2025 | Hdfc Bank Limited | ₹38.92 Lakh | Open |
| 04 Oct 2025 | Hdfc Bank Limited | ₹38.92 Lakh | Open |
| 25 Sep 2025 | Hdfc Bank Limited | ₹17.54 Lakh | Open |
| 24 Sep 2025 | Hdfc Bank Limited | ₹16.53 Lakh | Open |
| 05 Mar 2025 | Hdfc Bank Limited | ₹24.64 Lakh | Open |
Total charge records: 68 View all charges
Employees and EPFO Compliance at Sequent Scientific Limited
View historical data on people associated with Sequent Scientific Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Sequent Scientific Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Sequent Scientific Limited
GSTIN & GST Filing Data of Sequent Scientific Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Sequent Scientific Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Sequent Scientific Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Sequent Scientific Limited
MSME Payment Delays by Sequent Scientific Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Sequent Scientific Limited
Subsidiaries & Group Companies of Sequent Scientific Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Sequent Scientific Limited with ownership details.
MCA Filings & Documents of Sequent Scientific Limited
MCA Filings & Documents of Sequent Scientific Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Sequent Scientific Limited
Recent News on Sequent Scientific Limited
Frequently Asked Questions about Sequent Scientific Limited
Sequent Scientific Limited is an active public limited company in the chemicals sector based in Shaikpet, Telangana, India. It was incorporated on 28 June 1985 (41+ years old) and is registered under CIN L99999TS1985PLC196357. Listed on BSE: 512529 and NSE: EQUENT. The company has 399 employees.
Sequent Scientific Limited reported revenue of ₹1,566.06 Cr for FY 2025 (up 13.00% YoY).
The current directors of Sequent Scientific Limited are:
The primary industry of Sequent Scientific Limited is chemicals. The company specifically operates in pharmaceuticals. The company is currently active in this sector.
Yes. Sequent Scientific Limited is listed on both BSE (code: 512529) and NSE (symbol: EQUENT).
Sequent Scientific Limited can be reached at the registered office: 3Rd Floor Srivalli S Corporate Plot No. 290, Syn 33 34P To 39 Guttala Begumpet, Shaikpet, Telangana, India – 500033, or through the website sequent.in.